StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
CSL Limited
ASX:CSL.AX
Sector
Location
Market Cap
USD 77.29 B
Share Price
USD 159.49
Avg Daily Volume
834,388
Change (1 day)
-0.69%
Change (1 year)
-20.74%
Change (YTD)
-8.49%
CSL Limited Operating Cash Flow for the year ending June 30, 2024: USD 2.81 B
CSL Limited Operating Cash Flow is USD 2.81 B for the year ending June 30, 2024, a -27.27% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
CSL Limited Operating Cash Flow for the year ending June 30, 2023 was USD 3.87 B, a 6.68% change year over year.
-
CSL Limited Operating Cash Flow for the year ending June 30, 2022 was USD 3.62 B, a -0.56% change year over year.
-
CSL Limited Operating Cash Flow for the year ending June 30, 2021 was USD 3.65 B, a 41.74% change year over year.
-
CSL Limited Operating Cash Flow for the year ending June 30, 2020 was USD 2.57 B, a 60.01% change year over year.
Competitors
Illumina, Inc.
USD 99.27
ILMN
+2.12
2.18%
Revvity, Inc.
USD 100.66
RVTY
+1.95
1.98%
Syngene International Limited
USD 7.46
SYNGENE.NS
+0.08
1.12%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.24
002317.SZ
+0.02
0.95%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 4.38
688321.SS
-0.19
-4.25%
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%
Novartis AG
USD 122.54
NOVN.SW
+0.43
0.36%
Abbott Laboratories
USD 133.36
ABT
-0.34
-0.25%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Thermo Fisher Scientific Inc.
USD 426.17
TMO
+7.47
1.78%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Boston Scientific Corporation
USD 102.41
BSX
-1.42
-1.37%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Vertex Pharmaceuticals Incorporated
USD 466.36
VRTX
+6.95
1.51%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
RELX Plc
USD 53.63
REL.L
+0.13
0.24%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Illumina, Inc.
USD 99.27
ILMN
+2.12
2.18%
Revvity, Inc.
USD 100.66
RVTY
+1.95
1.98%
Syngene International Limited
USD 7.46
SYNGENE.NS
+0.08
1.12%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.24
002317.SZ
+0.02
0.95%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 4.38
688321.SS
-0.19
-4.25%
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%
Novartis AG
USD 122.54
NOVN.SW
+0.43
0.36%
Abbott Laboratories
USD 133.36
ABT
-0.34
-0.25%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Thermo Fisher Scientific Inc.
USD 426.17
TMO
+7.47
1.78%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Boston Scientific Corporation
USD 102.41
BSX
-1.42
-1.37%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Vertex Pharmaceuticals Incorporated
USD 466.36
VRTX
+6.95
1.51%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
RELX Plc
USD 53.63
REL.L
+0.13
0.24%